SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001105806-17-000010
Filing Date
2017-04-27
Accepted
2017-04-27 15:12:07
Documents
1

Document Format Files

Seq Description Document Type Size
1 axsm.txt SC 13G 4168
  Complete submission text file 0001105806-17-000010.txt   5354
Mailing Address 467 CPW NY NY 10025
Business Address
LYTTON LAURENCE W (Filed by) CIK: 0001105806 (see all company filings)

Type: SC 13G

Mailing Address 25 BROADWAY, 9TH FLOOR NEW YORK NY 10004
Business Address 25 BROADWAY, 9TH FLOOR NEW YORK NY 10004 212-203-5072
Axsome Therapeutics, Inc. (Subject) CIK: 0001579428 (see all company filings)

IRS No.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89198 | Film No.: 17788528
SIC: 2834 Pharmaceutical Preparations